UFPT trades 24.5% below Wall Street's consensus target of $298.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UFPT achieves its forward estimates and maintains a stable P/E multiple of 25.2x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, UFP Technologies, Inc. (UFPT) has a Wall Street consensus price target of $298.00, based on estimates from 2 covering analysts. With the stock currently trading at $239.28, this represents a potential upside of +24.5%. The company has a market capitalization of $1.85B.
Analyst price targets range from a low of $252.00 to a high of $344.00, representing a 31% spread in expectations. The median target of $298.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, UFPT trades at a trailing P/E of 27.3x and forward P/E of 25.2x. The forward PEG ratio of 0.67 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +8.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $291.42, with bear and bull scenarios of $183.59 and $383.97 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
PFBCPreferred Bank | $1.2B | $99.04 | $102.00 | +3.0% | Buy | 9.3x | 10 |
CPACCementos Pacasmayo S.A.A. | $1.1B | $12.70 | $12.80 | +0.8% | Hold | 8.8x | 8 |
ITGRInteger Holdings Corporation | $3.1B | $90.96 | $108.00 | +18.7% | Buy | 15.0x | 15 |
NNBRNN, Inc. | $147M | $2.79 | — | — | Buy | 39.9x | 9 |
ESABESAB Corporation | $6.5B | $106.20 | $138.25 | +30.2% | Buy | 18.4x | 10 |
LGNDLigand Pharmaceuticals Incorporated | $5.5B | $274.88 | $265.33 | -3.5% | Buy | 30.3x | 17 |
SEESealed Air Corporation | $6.2B | $42.15 | $49.92 | +18.4% | Buy | 12.4x | 27 |
SLGNSilgan Holdings Inc. | $4.4B | $41.65 | $50.50 | +21.2% | Buy | 10.9x | 21 |
PACKRanpak Holdings Corp. | $628M | $7.34 | $9.38 | +27.8% | Buy | — | 5 |
LYBLyondellBasell Industries N.V. | $19.4B | $60.07 | $80.20 | +33.5% | Hold | 6.4x | 39 |
Quick answers to the most common questions about buying UFPT stock.
The consensus Wall Street price target for UFPT is $298, representing 24.5% upside from the current price of $239.28. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
UFPT has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $298 implies 24.5% upside from current levels.
UFPT trades at a forward P/E of 25.1807x, representing a moderate valuation. With analysts targeting $298 (24.5% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $344 for UFPT, while the most conservative target is $252. The consensus of $298 represents the median expectation. Our quantitative valuation model projects a bull case target of $384 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UFPT is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UFPT stock forecast based on 2 Wall Street analysts shows a consensus price target of $298, with estimates ranging from $252 (bear case) to $344 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $291, with bear/bull scenarios of $184/$384.
Our quantitative valuation model calculates UFPT's fair value at $291 (base case), with a bear case of $184 and bull case of $384. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
UFPT trades at a forward P/E ratio of 25.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on UFPT, with a "Buy" consensus rating and $298 price target (24.5% upside). 2 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UFPT analyst price targets range from $252 to $344, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $298 consensus represents the middle ground. Our model's $184-$384 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.